首页> 美国卫生研究院文献>Tuberculosis Research and Treatment >Predictors of Treatment Outcome for Retreatment Pulmonary Tuberculosis Cases among Tribal People of an Eastern India District: A Prospective Cohort Study
【2h】

Predictors of Treatment Outcome for Retreatment Pulmonary Tuberculosis Cases among Tribal People of an Eastern India District: A Prospective Cohort Study

机译:印度东部地区部落居民再治疗肺结核病例的治疗结果预测指标:一项前瞻性队列研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective. The study was conducted to assess the treatment outcome of different category retreatment cases with the aim of finding out the important predictors of unfavorable outcomes. Methodology. This hospital based prospective cohort study was conducted in three tuberculosis units (TUs) of west Midnapore (a district of Eastern India), covering mostly the tribal populated areas. Patients who were registered for Category II antituberculosis treatment between 1st quarter of 2013 (Jan to Mar) and 4th quarter of 2013 (Oct to Dec) were considered as our study cohort and they were followed up till December 2014. The study was started with 177 patients but ultimately ended with 165 patients. Results. Unfavorable outcome was observed among 24.8% patients. Among them mostly 51.2% were defaulter, 22% were failure case, and 26.8% died during treatment. Patients, who were minority by religion, were found 4 times more vulnerable for unfavorable outcome. Unfavorable outcome was found 7 times more common among retreatment TB cases who remain sputum positive after completion of initiation phase of Category II treatment. Conclusion. Programmatic approach should be specified to address the minority by religion population and to reduce the load of sputum positive cases after completion of initiation phase treatment by tracking them.
机译:目的。该研究旨在评估不同类别再治疗病例的治疗结果,以找出不良结果的重要预测因素。方法。这项基于医院的前瞻性队列研究是在西米德纳坡(印度东部的一个地区)的三个结核病单位(TU)中进行的,大部分覆盖了人口稠密的部落地区。在2013年第1季度(1月至3月)至2013年第4季度(10月至12月)期间注册接受II类抗结核治疗的患者被视为我们的研究队列,并随访至2014年12月。该研究始于177病人,但最终以165名病人告终。结果。在24.8%的患者中观察到不利的结果。其中,有51.2%的人是违法者,有22%的人是失败者,有26.8%的人在治疗期间死亡。宗教上属于少数的患者因不良后果而变得脆弱的四倍。在II类治疗起始阶段完成后仍保持痰液阳性的再治疗结核病例中,不良结果的发生率高出7倍。结论。应指定程序性方法,以按宗教信仰人群解决少数群体问题,并通过跟踪开始阶段的治疗完成后减少痰阳性病例的负担。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号